Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Non-Current Deferred Tax Liability (2020 - 2025)

Historic Non-Current Deferred Tax Liability for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q2 2025 value amounting to $2.0 million.

  • Maravai Lifesciences Holdings' Non-Current Deferred Tax Liability changed N/A to $2.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $11000.0 for FY2024, which is N/A changed from last year.
  • As of Q2 2025, Maravai Lifesciences Holdings' Non-Current Deferred Tax Liability stood at $2.0 million.
  • Over the past 5 years, Maravai Lifesciences Holdings' Non-Current Deferred Tax Liability peaked at $8.7 million during Q1 2023, and registered a low of $11000.0 during Q4 2024.
  • For the 4-year period, Maravai Lifesciences Holdings' Non-Current Deferred Tax Liability averaged around $5.2 million, with its median value being $6.7 million (2023).